Search Results - "Borrego Izquierdo, Y."

Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy by Jiménez-Galán, Rocío, Cuenca, María-Rosa Cantudo, Robustillo-Cortés, María Aguas, Borrego Izquierdo, Y., Almeida-Gonzalez, Carmen Victoria, Morillo-Verdugo, Ramón

“…Decreased antiretroviral therapy persistence is associated with increased rates of virologic failure, development of antiretroviral resistance, and increased…”
Get full text

CP-205 Evolution of the persistence to nucleos(T)ide analogue treatment for patients with chronic hepatitis B by Izquierdo, Y Borrego, García, M Manzano, Cortes, Mdla Robustillo, Guzman, MD Toscano, Fernández, E Gómez, Rocío, JG, Cuenca, MR Cantudo, Verdugo, R Morillo

“…BackgroundPatients with chronic hepatitis B (CHB) require long treatment in order to be able to achieve and maintain viral suppression. Therapy health outcomes…”
Get full text

Potentially inappropriate medications according to Marc, STOPP and PRISCUS criteria in a cohort of elderly HIV+ patients. The COMMPI project by García-Lloret, P, Borrego-Izquierdo, Y, Manzano-García, M, Cantillana-Suárez, M G, Gutiérrez-Pizarraya, A, Morillo-Verdugo, R

“…The objective is to determine the prevalence of potentially inappropriate drugs according to the Marc, STOPP, and PRISCUS lists in elderly HIV patients. It was…”
Get full text

Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy by Jiménez-Galán, Rocio, Cantudo Cuenca, Maria-Rosa, Robustillo-Cortés, María Aguas, Borrego Izquierdo, Y, Almeida-Gonzalez, Carmen Victoria, Morillo-Verdugo, Ramón

“…Decreased antiretroviral therapy persistence is associated with increased rates of virologic failure, development of antiretroviral resistance, and increased…”
Get more information

New drugs in the treatment of chronic hepatitis C by Jimenez Galan, R, Albacete Ramirez, A, Monje Agudo, P, Borrego Izquierdo, Y, Morillo Verdugo, R

“…To analyze the efficacy and safety of the new direct antiviral agents (DAA) that will become the new therapeutic arsenal for the treatment of hepatitis C. We…”
Get more information